NPPB and myalgic encephalomeyelitis/chronic fatigue syndrome: The CFS demonstrated remarkable capacity to identify patients at the highest risk, with the increased risk associated with severe frailty remaining consistent across genotypes, NAC disease stages, renal function (a key prognostic factor among older individuals), NT-proBNP levels, NYHA functional classes, and age brackets.